Varicella vaccination in Europe - taking the practical approach. - Wikidata - wikimedia - TriplyDB

Varicella vaccination in Europe - taking the practical approach.

Varicella vaccination in Europe - taking the practical approach.

http://www.wikidata.org/entity/Q33454919

about

Microbiology laboratory and the management of mother-child varicella-zoster virus infection Evaluation of efficacy and effectiveness of live attenuated zoster vaccine Negative attitude and low intention to vaccinate universally against varicella among public health professionals and parents in the Netherlands: two internet surveys Specific capture and whole-genome sequencing of viruses from clinical samples Time trends in pediatric hospitalizations for varicella infection are associated with climatic changes: a 22-year retrospective study in a tertiary Greek referral center.Varicella susceptibility and transmission dynamics in Slovenia.Varicella vaccination coverage of children under two years of age in Germany Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015 The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.Hospitalization due to varicella in the Netherlands A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008.The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey.Successes and challenges in varicella vaccine The controversy of varicella vaccination in children with acute lymphoblastic leukemia.Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011 Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.Safety of a second dose of varicella vaccine administered at 4 to 6 years of age in healthy children in Argentina.Varicella-zoster virus susceptibility and primary healthcare consultations in Norway.Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.Varicella paediatric hospitalisations in Belgium: a 1-year national survey Clinical epidemiology of chickenpox in Iraq from 2007-2011 Vaccine effectiveness evaluation during a varicella outbreak among children of primary schools and day-care centers in a region which adopted UMV Economic evaluation of Varicella vaccination: results of a systematic review.Molecular studies of the Oka varicella vaccine.Acceptance on the move: public reaction to shifting vaccination realities.Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples.Clinical and molecular aspects of the live attenuated Oka varicella vaccine.Has VZV epidemiology changed in Italy? Results of a seroprevalence study.Vaccination Coverage Disparities Between Foreign-Born and U.S.-Born Children Aged 19-35 Months, United States, 2010-2012.Monitoring prevalence of varicella-zoster virus clades in Germany.Preparing to introduce the varicella vaccine into the Italian immunisation programme: varicella-related hospitalisations in Tuscany, 2004-2012.Varicella and secondary pneumonia in a healthy child: is it time to introduce varicella vaccine in the UK?Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.Heterogeneity in coverage for measles and varicella vaccination in toddlers - analysis of factors influencing parental acceptance Serological Susceptibility to Varicella Among U.S. Immigration and Customs Enforcement Detainees.Chickenpox vaccination.Varicella and herpes zoster vaccine development: lessons learned.

P2860

Q26738745-F884E8A2-F18D-4BF4-A1A7-0DBC308BB066 Q26866473-E1674767-8725-404F-9698-48C6D264456E Q27312388-C65E8B5E-6C2B-41D0-A59F-39CC1EDB7393 Q28742542-EA3CEDBF-E297-45A5-AECC-80E2F546CE8F Q30584282-71BF2FED-D27A-47A9-9C50-DE4DA4CA27B6 Q33614198-5F607CE3-1943-409B-9B46-69D887370C1E Q33665393-A2BCEBAC-62A3-4CE5-8A07-186FABDD3871 Q33698107-B83CC29D-456F-4B9C-B0A7-D44798260F42 Q33703581-0F814A59-7774-446F-83BC-173E25B7D3AE Q33706387-0207E989-6AC3-4FBE-B1C4-3CD42571BC48 Q33863210-CBD7FE13-504E-4607-B30F-A5585318FC67 Q33923167-18BEE346-5C31-416E-9D7B-49C9FE37982D Q34076833-5CA0EE20-ABA3-4FDF-9F46-8C8202481396 Q34416710-E7A0DF0D-7A2C-4586-A1CF-93FD26AB85B9 Q34419709-649C2ED5-08FD-42CA-A7D7-1241A810B9E5 Q34788015-DCDD9025-6E86-49DE-A184-936EF2FA3FCE Q35652212-7E6A96D4-FFC6-4CC5-AB91-F81D2C75C5CD Q35667367-EC4D2BE1-1930-4A95-B77E-56098AECA403 Q36041839-BA571FD9-C78E-4135-A612-7ED8571BB138 Q36149754-ECA2D9B5-6EA4-43CB-A3A9-3AB4AE744051 Q36154756-CC3DD46F-8BC9-449E-A1F7-1DEED3C466DD Q36252698-387C10F5-3830-40A4-889A-919957970FF0 Q36475701-2D972AEA-C8AE-4F41-9927-9DC7AC23E3F5 Q36648339-EF06C867-8469-4846-8388-5BC15581FF28 Q36887989-CABEA947-B568-46A0-AFE2-4B0B1E54E64B Q37530362-BBD4C374-5067-4BC6-B8F8-1D21017BA766 Q37932527-308BFB11-1D92-4E7A-B280-F11CBAA6889B Q37959648-49FB6754-678B-4254-9A1E-694D89126892 Q38105340-8FB850A3-8231-4E49-9FF7-4FA1842A88F1 Q38200971-81CB73F5-994C-4312-8628-9DE7AE0D8FB7 Q39062406-C65185B2-45B6-4B89-AE1A-220CB2FB5AA5 Q39537239-2CFF2900-F84D-4550-89EC-8C9D0285D14C Q39632682-BFBF71F8-06B1-48CE-A24F-17031304EF83 Q39660715-6CF6B00F-1090-425D-9C14-7738C0384410 Q40232212-D95A7FDF-8F85-4F0D-AE65-0EFBC01758CF Q40590813-D7035B23-B85F-4787-A00D-AD8752B62787 Q41712130-A8F008E6-BE09-47FC-9F06-2908AF68B798 Q41930849-F424AC72-E828-4B9B-BE4E-D51F145CD66F Q46104517-7FF65338-4EE7-4FBA-81EC-43496A8347F0 Q47607699-E2404F37-4161-4E14-B956-6A539D84D642

P2860

Varicella vaccination in Europe - taking the practical approach.

http://www.wikidata.org/entity/Q33454919

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Varicella vaccination in Europe - taking the practical approach.

@ast

Varicella vaccination in Europe - taking the practical approach.

@en

type

label

Varicella vaccination in Europe - taking the practical approach.

@ast

Varicella vaccination in Europe - taking the practical approach.

@en

prefLabel

Varicella vaccination in Europe - taking the practical approach.

@ast

Varicella vaccination in Europe - taking the practical approach.

@en

P1433

Q33454919-1994C8FA-09A1-41A1-A93F-F8F4A9818758

P1476

Q33454919-2F365777-1E4A-4DF8-B5ED-7B8DDEFE8BC9

P2093

Q33454919-0AA7336B-0FA2-4CFE-9C80-0EFB8587A86E

Q33454919-280403AB-9AA1-4150-BA03-907D7993098C

Q33454919-2C7CCC6A-C72A-4F18-B2D1-27FFEE0F7A21

Q33454919-45502918-D86D-48BC-992B-A0FAC809CF3B

Q33454919-4BEF9E03-3005-44B3-8573-8866A53D1A6F

Q33454919-5DCC6B77-A9C6-48A3-AF38-87252F0C4F54

Q33454919-73F3FD72-FE21-4634-A912-E5A870A8D1EE

Q33454919-907724AD-32BC-4A33-B53A-AF81F088A6D4

Q33454919-9FC3909D-62BC-490E-9848-9FB6B263DD9B

Q33454919-CF23E558-D1B5-4DC2-B068-D313741BD996

P275

Q33454919-D69C4503-5EA2-406E-92D7-A693F2B03A50

P2860

Q33454919-00F56C14-F06E-47F1-B801-E227D07F5D94

Q33454919-01C56C84-95A2-4DA5-B0FB-A15033392044

Q33454919-02AF3686-AA7E-4A00-9CA6-8F2DD6E0609A

Q33454919-0446D0F8-6D34-493E-8FFC-EC6B9C6FFB7E

Q33454919-08D268E4-4727-4D2C-9BB6-A2714FFC0745

Q33454919-0D996836-44B2-45A6-AA77-C7EA99643C2D

Q33454919-19BE4AA8-FE03-4594-A9F9-B6BA4CB174BC

Q33454919-1ACA9097-F363-4EAB-8B8E-B945CF6D61E6

Q33454919-1B7CF19D-A3A1-4ACA-8859-738D51FB3055

Q33454919-1D08A6ED-5549-477A-A9D0-CE129F36AEF5

P2888

Q33454919-73CCEAF2-FC8C-44A5-92BD-F29AB0EC477A

P304

Q33454919-06E316D3-8E3D-4FCE-A374-B1761C091E11

P31

Q33454919-5809A4D8-664D-4056-B6B4-73CEB371D42F

Q33454919-C391D8BB-C192-40D0-A93F-26AFFA264EB1

P356

Q33454919-B2BE270A-2D56-45FB-AD74-2EEBF011292F

P407

Q33454919-F4E03C2F-31A1-43E1-8C5C-05FD7E73A18C

P478

Q33454919-361E2CDC-439B-4C99-BE80-86B42DAFD217

P50

Q33454919-8FEC94F7-B446-4A8F-BF96-6BA8976FA1DB

P5008

Q33454919-296ABB20-FB6F-4577-9219-01981FA63845

P577

Q33454919-FC3B3471-CA11-41CC-8AF2-AE751857295A

P5875

Q33454919-F37C270B-BAA2-4BAE-BD1B-4A65E3D2B0EA

P6179

Q33454919-57503863-2810-4B4D-9D2D-8EFA713880E3

P698

Q33454919-6D864718-4CF6-4482-BEC3-498F1951CA29

P921

Q33454919-184B0E73-D596-43C8-B5D5-E189FADBA349

Q33454919-28B89D1B-7756-4B35-B739-9C3C7346F094

Q33454919-7D9EDA90-90CF-4842-BEA0-65E41781FB35

Q33454919-FE58BEA6-70B7-417C-BC0D-6F93DD678D2F

P932

Q33454919-C97CF1CE-01F7-417D-8CEF-1500B292897A

P356

P1433

P1476

Varicella vaccination in Europe - taking the practical approach.

@en

P2093

Anne Gershon

http://www.w3.org/2001/XMLSchema#string

Bernard Rentier

http://www.w3.org/2001/XMLSchema#string

Catherine Sadzot-Delvaux

http://www.w3.org/2001/XMLSchema#string

Catherine Weil-Olivier

http://www.w3.org/2001/XMLSchema#string

Hans Rümke

http://www.w3.org/2001/XMLSchema#string

Jacques Senterre

http://www.w3.org/2001/XMLSchema#string

Michael Gershon

http://www.w3.org/2001/XMLSchema#string

Paolo Bonanni

http://www.w3.org/2001/XMLSchema#string

Peter Wutzler

http://www.w3.org/2001/XMLSchema#string

Vana Papaevangelou

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

The incidence of herpes zoster in a United States administrative database

Epidemiology of varicella zoster virus infection in Canada and the United Kingdom

Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

What does epidemiology tell us about risk factors for herpes zoster?

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

Varicella disease after introduction of varicella vaccine in the United States, 1995-2000

Varicella vaccines. WHO position paper

Loss of vaccine-induced immunity to varicella over time

Decline in mortality due to varicella after implementation of varicella vaccination in the United States

P2888

P304

26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1741-7015-7-26

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2009-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26247894

http://www.w3.org/2001/XMLSchema#string

P6179

1031751070

http://www.w3.org/2001/XMLSchema#string

P698

19476611

http://www.w3.org/2001/XMLSchema#string

P921

Herpesviridae infectious disease

preventive health services

biomedical investigative technique

P932

2697173

http://www.w3.org/2001/XMLSchema#string